Page last updated: 2024-11-07

penicillamine and Adiadochokinesis

penicillamine has been researched along with Adiadochokinesis in 1 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Research Excerpts

ExcerptRelevanceReference
"A 38-year-old woman with Wilson's disease developed neurological deterioration after 25 years of low-dose penicillamine administration."1.38Resolution of cranial MRI and SPECT abnormalities in a patient with Wilson's disease following oral zinc monotherapy. ( Doi, Y; Fukui, H; Hanafusa, T; Ishida, S; Kimura, F; Sugino, M; Tamai, H; Yamane, K, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishida, S1
Doi, Y1
Yamane, K1
Sugino, M1
Kimura, F1
Hanafusa, T1
Fukui, H1
Tamai, H1

Other Studies

1 other study available for penicillamine and Adiadochokinesis

ArticleYear
Resolution of cranial MRI and SPECT abnormalities in a patient with Wilson's disease following oral zinc monotherapy.
    Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:13

    Topics: Adult; Brain; Cerebellar Ataxia; Cerebrovascular Circulation; Female; Hepatolenticular Degeneration;

2012